Close Menu

NEW YORK – Illumina said this week that it was notified of an unsolicited "mini-tender offer" by TRC Capital to purchase up to 500,000 shares of Illumina common stock at a price of $268.80 per share in cash. Illumina noted that the offer is subject to a number of conditions, including TRC's ability to obtain sufficient funding, and that the offer will expire at 12:01 am on Oct. 3.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.

Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.

Washington Post columnist writes that she is skeptical about DNA-based diets.

In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.